Skip to main content
. 2014 Aug;88(16):9406–9417. doi: 10.1128/JVI.01031-14

TABLE 1.

1086.C gp140 binding to CD4i epitope-specific MAb 17B in the absence or presence of various C1-specific antibodies and control antibodiesa

Antibody 17B binding response (RU) % upregulation
None 357 ± 37 0.0
Synagis 363 ± 38 1.8
A32 636 ± 40 78.3
CH29 386 ± 24 8.1
CH38 756 ± 44 111.9
CH40 361 ± 39 1.2
CH51 408 ± 44 14.4
CH52 430 ± 48 20.5
CH54 474 ± 51 32.9
CH77 358 ± 24 0.3
CH78 292 ± 37 −17.9
CH81 433 ± 47 21.5
CH89 477 ± 53 33.7
CH90 358 ± 38 0.5
CH91 633 ± 65 77.5
CH92 362 ± 38 1.6
CH94 382 ± 26 7.2
CH29 IgA2 369 ± 22 3.6
CH38 IgA2 673 ± 41 88.7
a

The 17B binding experiment was performed, and the percent upregulation was calculated as described in Materials and Methods. An average of three measurements of 17B binding and the estimated standard deviations are shown.